Endurance of erythrocyte series in chemotherapy

Hematopoietic bone marrow toxicity is most often the limiting factor for chemotherapy doses. Increasing the intensity of chemotherapy doses (higher doses or more frequent administration) would improve antitumor effects, but the hematological toxicity does not allow these dose increases. This study e...

Descripción completa

Detalles Bibliográficos
Autores principales: Săftescu, Sorin, Popovici, Dorel, Oprean, Cristina, Negru, Alina, Croitoru, Adina, Zemba, Mihail, Yasar, Ionela, Preda, Maria, Negru, Șerban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604759/
https://www.ncbi.nlm.nih.gov/pubmed/33149778
http://dx.doi.org/10.3892/etm.2020.9344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604759/
https://www.ncbi.nlm.nih.gov/pubmed/33149778
http://dx.doi.org/10.3892/etm.2020.9344

Ejemplares similares